What side effects are associated with this type of intervention?

Treatments for nasal obstruction, particularly those involving surgical interventions like bioabsorbable implants for septal deviation, can have side effects such as infection, bleeding, and postoperative pain. Non-surgical treatments, including nasal corticosteroids and decongestants, may cause nasal irritation, dryness, and systemic effects with long-term use. It is important to discuss these potential side effects with a healthcare provider to determine the most appropriate treatment.

What prior FDA approvals exist?

The FDA has approved several treatments for nasal obstruction, including bioabsorbable implants designed to provide structural support and correct septal deviation. One such example is the Propel sinus implant, which is used post-surgery to maintain sinus patency and deliver localized steroid therapy. These implants are designed to be absorbed by the body over time, reducing the need for additional surgical interventions. Other treatments include traditional septoplasty and the use of silicone stents, although these do not offer the same bioabsorbable benefits.

What other types of research exist?

Promising novel alternatives to bioabsorbable implants for nasal obstruction patients include endobronchial valve therapy and sublingual immunotherapy (SLIT). Endobronchial valve therapy, typically used for emphysema, has shown potential in improving airflow and could be adapted for nasal obstruction. SLIT, primarily used for allergic rhinitis, offers a non-invasive approach to managing nasal obstruction by reducing allergic inflammation and improving nasal airflow.

← Back to Search

Procedure

Investigational Device for Nasal Obstruction

Verified Trial

N/A

Recruiting

Research Sponsored by Spirair, Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥21 to ≤ 64 years of age at time of consent

Seeking treatment for nasal airway obstruction (NAO) symptoms due primarily to cartilaginous nasal septal deviation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial tested a new implant and delivery system to fix a deviated septum, a common breathing problem.

Who is the study for?

Adults aged 21-64 with a deviated septum causing nasal blockage, who are seeking treatment and willing to undergo an implant procedure. Participants must have significant symptoms (NOSE score ≥30), speak English, and be able to follow the study protocol. Excluded are those with prior nose surgeries, concurrent ENT procedures other than turbinate reduction, certain nasal deformities or conditions, active infections at the site of implantation, recent drug abuse history, pregnant or breastfeeding women, and anyone unable to comply with the study requirements.Check my eligibility

What is being tested?

The trial is testing a new bioabsorbable Spirair Nasal Device implanted using a special delivery system designed for people with nasal airway obstruction due to septal deviation. It's an open-label pilot study which means everyone gets the device and knows what they're receiving.See study design

What are the potential side effects?

Potential side effects may include local reactions at the implant site like swelling or infection, discomfort from the procedure itself, possible allergic reactions if sensitive to materials in the device such as poly(dioxanone), and complications related to wound healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 21 and 64 years old.

Select...

I am looking for treatment because my nose is blocked due to a bent nasal septum.

Select...

I am willing to have a nasal implant procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Primary Effectiveness Endpoint

Primary Safety Endpoint

Secondary outcome measures

Secondary Endpoint - 1

Secondary Endpoint - 2

Secondary Endpoint - 3

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Investigational DeviceExperimental Treatment1 Intervention

Treatment with the Spirair Septal correction device and delivery system for correction of cartilaginous nasal septal deviation.

0 / 3Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common treatments for nasal obstruction, such as bioabsorbable implants, work by providing structural support to correct anatomical issues like septal deviation. These implants temporarily support the nasal septum, allowing it to heal in a corrected position before being absorbed by the body. This mechanism is crucial for nasal obstruction patients as it addresses the root cause of the obstruction, offering a potential long-term solution without the need for permanent implants or repeated surgeries.

Find a Location

Who is running the clinical trial?

Spirair, IncLead Sponsor

Brandon McCutcheon, MDStudy DirectorSpirair, CMO

~10 spots leftby Sep 2024

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.